Medindia
Medindia LOGIN REGISTER
Advertisement

Actinium Achieves Fifty Percent Enrollment in the Pivotal Phase 3 SIERRA Trial for Iomab-B

Tuesday, July 23, 2019 General News
Advertisement
- Midpoint reached as 75th patient dosed in Phase 3 SIERRA trial

Sponsored Post and Backlink Submission


Latest Press Release on General News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close